Biomedicines (Feb 2023)

Muscle and Muscle-like Autoantigen Expression in Myasthenia Gravis Thymus: Possible Molecular Hint for Autosensitization

  • Nicola Iacomino,
  • Letizia Scandiffio,
  • Fabio Conforti,
  • Erika Salvi,
  • Maria Cristina Tarasco,
  • Federica Bortone,
  • Stefania Marcuzzo,
  • Ornella Simoncini,
  • Francesca Andreetta,
  • Daniela Pistillo,
  • Emanuele Voulaz,
  • Marco Alloisio,
  • Carlo Antozzi,
  • Renato Mantegazza,
  • Tommaso Martino De Pas,
  • Paola Cavalcante

DOI
https://doi.org/10.3390/biomedicines11030732
Journal volume & issue
Vol. 11, no. 3
p. 732

Abstract

Read online

The thymus is widely recognized as an immunological niche where autoimmunity against the acetylcholine receptor (AChR) develops in myasthenia gravis (MG) patients, who mostly present thymic hyperplasia and thymoma. Thymoma-associated MG is frequently characterized by autoantibodies to the muscular ryanodine receptor 1 (RYR1) and titin (TTN), along with anti-AChR antibodies. By real-time PCR, we analyzed muscle—CHRNA1, RYR1, and TTN—and muscle-like—NEFM, RYR3 and HSP60—autoantigen gene expression in MG thymuses with hyperplasia and thymoma, normal thymuses and non-MG thymomas, to check for molecular changes potentially leading to an altered antigen presentation and autoreactivity. We found that CHRNA1 (AChR-α subunit) and AIRE (autoimmune regulator) genes were expressed at lower levels in hyperplastic and thymoma MG compared to the control thymuses, and that the RYR1 and TTN levels were decreased in MG versus the non-MG thymomas. Genes encoding autoantigens that share epitopes with AChR-α (NEFM and HSP60), RYR1 (neuronal RYR3), and TTN (NEFM) were up-regulated in thymomas versus hyperplastic and control thymuses, with distinct molecular patterns across the thymoma histotypes that could be relevant for autoimmunity development. Our findings support the idea that altered muscle autoantigen expression, related with hyperplastic and neoplastic changes, may favor autosensitization in the MG thymus, and that molecular mimicry involving tumor-related muscle-like proteins may be a mechanism that makes thymoma prone to developing MG.

Keywords